Medical Practice (1988–2023)
Hisham Abdullah started his medical career as a houseman at the Kuala Lumpur University Hospital in 1988,and later in the Accident and Emergency Department in 1989.
Upon receiving Master of Surgery,he was appointed as a general surgeon in Kuala Terengganu Hospital in 1994. After three years as a general surgeon,Hisham went on endocrinology fellowship training at various institutes in Australia.
Once returning from his fellowship in Australia,Hisham Abdullah was appointed as the head of the Breast and Endocrine Surgery Unit at the Kuala Lumpur Hospital in 1999. Three years later,in 2002,he took on the role of Head and Senior Consultant of Breast and Endocrine Surgery at Putrajaya Hospital,a position that he held until his retirement. Noor Hisham Abdullah was also the royal physician to the King of Malaysia during his clinical years.
As one of the pioneer in breast and endocrine surgery in Malaysia,Hisham Abdullah led the development of the service in the Ministry of Health,Malaysia. Through his leadership,an Endocrine Institute was built in Putrajaya Hospital. The new complex was officiated by then Health Minister,Khairy Jamaluddin in April 2022. [20]
He is an expert in performing thyroidectomy under local anaesthesia,and incorporated acupuncture-assisted anaesthesia (AAA) in his technique. Hisham performed the first thyroidectomy with AAA at Raja Permaisuri Bainun Hospital,Ipoh with fellow consultant surgeon,Dr Yang Yang Wai,and Head of Anaesthesia Department,Dr Kavita M. Bhojwani in August 2015. [21]
Hisham Abdullah has published in local and international journals,with a chapter entitled “Multinodular Goiter”in the Textbook of Endocrine Surgery,2009 (Hubbard and C Y Lo,New York),and a chapter entitled “External Laryngeal Nerve”in the Textbook of Thyroid and Parathyroid Surgery 2010 (Randolph G). He has been on the editorial review board for several journals such as the Asian Journal of Surgery,Malaysian Medical Journal,and World Journal of Surgery. [22]
Hisham had several special appointments such as the Royal Australasian College of Surgeons foundation visitor in Hong Kong in 2008 and Goatcher Surgeon in Residence for the Royal Perth Hospital in 2013. [23] [24]
For his work in advancing technique in difficult and complex endocrine surgery,Hisham was frequently invited to present at the international surgical conferences. [25] The most notable lecture was given at the 48th World Congress of Surgery in Krakow,Poland when he delivered the Martin Allgöwer opening lecture in 2019, [26] [27] and the British Journal of Surgery Lecture,entitled “Investigation and Management of Retrosternal Goitre”in the 2010 Annual Meeting of the British Association of Endocrine and Thyroid Surgeons (BAETS) in Birmingham. [22]
In the recognition of his service to the breast and endocrine surgery,Hisham Abdullah was elected chair of the Global Surgery Committee of the International Society of Surgery (ISS) in 2017. [27] Hisham was also elected as the President of the Asian Association of Endocrine Surgeons (AsianAES). [28]
Hisham Abdullah received the Excellence Service Award in 2000 and 2004 for the recognition of his service in Kuala Lumpur Hospital (HKL) and Putrajaya Hospital respectively. [2] [29] For his contributions in improving the nation’s health through various reforms and innovations coupled with the advancement of endocrine surgery,surgical training and research in Malaysia,Hisham was awarded the Fellowship Ad Hominem of the Royal College of Surgeons of Edinburgh (RCSEd) in February 2018. [30] [25] Three years later,he was awarded an international medal by the RCSEd to recognise his contribution for the surgery in Malaysia. [31]
Director-General of Health (2013–2023)
Hisham Abdullah was the Deputy Director-General of Health (Medical) for five years from February 2008 before being promoted as the Director-General of Health in March 2013. [32] He is one of the youngest Director-General of Health ever appointed by the Ministry of Health.
Role during the COVID-19 pandemic in Malaysia
Hisham Abdullah was the Director-General of Health in charge during the COVID-19 pandemic in Malaysia. In the National Crisis Preparedness and Response Centre (CPRC) formed by the Ministry of Health,the Director-General of Health chairs the Executive Committee for Disaster Management,which forms the central decision-making committee related to technical issues,with subsequent flow of command to a national technical committee,the National CPRC,and operations rooms at state as well as district levels. [33] Hisham Abdullah was acknowledged for his role as a competent leader;effective manager,and diligent personnel in tackling the unprecedented COVID-19 pandemic. [34]
Following the 2020 Malaysian political crisis,Hisham Abdullah stepped into COVID-19 press briefing during the political power vacuum period. In order to provide a clear risk communication and cultivate confidence from the nation during global health crisis, [35] the cabinet agreed that Hisham should continue the national COVID-19 daily press briefing despite the appointment of the new Health Minister,Dr. Adham Baba,who was widely criticised when he falsely claimed that drinking warm water can protect from COVID-19. [11] [36] [37]
Hisham's daily COVID-19 briefings were praised for his calm and clarity during the global health crisis. [16] [38] He was acknowledged for effective crisis communication which has reassured most Malaysians by delivering facts since the beginning of the Movement Control Order (MCO). [39] [40] Daily press conference at 1700 hours followed by press dialogues clearly enhanced the chain of information from the Ministry of Health to the nation. [34] Through this regular press conference,the Malaysian government was able to deploy a consistent risk communication approach,with Hisham Abdullah emerged as a familiar,apolitical leader in the midst of political calamity,representing united health system frontline health care workers and a trusted conveyor of new data and evidence. [41]
On 6 April 2020,Hisham Abdullah announced that Malaysia had started the worldwide Solidarity Trial by the WHO to collect reliable data and compare the safety and effectiveness of four COVID-19 treatment protocols using different combinations of Remdesivir,Lopinavir/Ritonavir,Interferon beta,Chloroquine and Hydroxychloroquine. [42]
In the same month of April 2020,Drugs for Neglected Diseases initiative (DNDi) announced that Hisham had joined the COVID-19 Clinical Research Coalition to accelerate research into the pandemic in often neglected resource-poor settings. [43] [44]
The China Global TV Network (CGTN),had recognised Dr. Noor Hisham as among the “top doctors”of the world alongside America's Dr. Anthony Fauci and New Zealand's Dr. Ashley Bloomfield for the handling of COVID-19 pandemic. [19] [45] He also was named again among the COVID-19 heroic trio by Singaporean news outlet,The Independent. [46]
Role in Improving Equity and Access to the Treatment of Hepatitis C and Eliminating Hepatitis C in Malaysia
Malaysia as a developing country is often caught in a middle-income nation trap where some drugs are patented and access to new drugs is impossible due to exorbitant price despite the availability of generic drugs elsewhere. With the assistance of Third World Network (TWN),Drugs for Neglected Diseases initiative (DNDi),and Médecins Sans Frontières/Doctors Without Borders (MSF),Hisham provided a leadership and direction to improve access and equity for the Hepatitis C treatment in Malaysia. [47] [48]
In 2017,the Ministry of Health,Malaysia initiated a negotiation with Gilead Sciences Inc for the voluntary license of a miracle drug for Hepatitis C,Sofosbuvir. Despite multiple efforts,negotiation broke down and forced Malaysia to issue compulsory license in an effort to increase accessibility of the drug which was previously priced at €43,000 for one person’s 12-week treatment of sofosbuvir. [49] Due to the exorbitant price,the Ministry of Health,Malaysia then decided to trigger Doha Declaration on TRIPS and Public Health (Doha Declaration) in 2001 by member nations of the World Trade Organisation,in order to bring down the cost of the treatment to USD300 per course thus sparking hostile legal backlash from Gilead Sciences Inc and the United States.
In response to Malaysia's action,Gilead then announced on Twitter that it had included Malaysia in the voluntary license for its wonder drug Sofosbuvir. [50] Hisham faced gruelling cross-examinations by the patent lawyers and the Medicines Patent Pool (MPP) committee in Geneva to defend the country's decision to issue a compulsory license for Sofosbuvir.
In his leadership as the Director-General of Health,Malaysia also started a new drug trial for Hepatitis C treatment with DNDi. [51] This then lead to the improvement in the treatment of Hepatitis C with much greater success cure rate with the introduction of Ravisdavir. It is the first drug produced through south-south collaboration to improve access and equity for the treatment of Hepatitis C. In August 2023,World Health Organisatio n (WHO) included Ravidasvir in the list of essential medicine (EML). [52]
Role in Advancing Global Surgery Initiative
Through the Ministry of Health team,Hisham led Malaysia and WHO Western Pacific Region to develop the Action framework for Safe and Affordable Surgery in the WHO Western Pacific Region (2021-2030). [53]
In Malaysia,94% of the population have access to basic surgery. Yet,this figure masks important differences within the country,with two million people in East Malaysia without access to timely surgery and waiting times for elective surgery more than six months. Hence,through the Global Surgery Initiative,Malaysia strategically targeting these and other areas of need based on an analysis of waiting times,geographical distribution of surgical facilities by level and other performance indicators. [54]
As a breast and endocrine surgeon,Hisham regularly participated in teaching and training the difficult thyroidectomy procedure,most notably in Malaysia Field Hospital in Cox's Bazaar. [55]
Through this global surgery initiative,the Ministry of Health developed smart partnership with the Federal Territories Islamic Religious Council (MAIWP) and built the MAIWP Cataract Surgery Centre in Selayang that offers free cataract surgery for underprivileged patients as compared to RM3,000 in private hospital or eye clinic. [56] [57] Additionally,Hisham led the Ministry of Health to develop Klinik Katarak KKM to eliminate preventable blindness by delivering high-quality cataract surgery to underserved populations in Borneo. [58]
To ensure good surgical outcome when delivering these services,the Ministry of Health partnered with the International Agency for the Prevention of Blindness (IAPB) via E-Cusum initiative that managed to reduce post-cataract surgery complication to less than 0.2% in 2017. By contrast,up to 36% patient were unable to see 6/60 and 1.5% developed blindness following cataract surgery in certain countries. [59]
In expanding global surgery initiative,the WHO Executive Board (EB152/3) recommend that the World Health Assembly adopted a resolution on “Integrated emergency,critical and operative care for universal health coverage and protection from health emergencies”in April 2023. The emergency,critical and operative care services are an integral part of a comprehensive primary health-care approach and are essential to meet people’s health needs. [60]
Role in Health for All
Alongside the Health Minister,Dr. Zaliha Mustafa,Hisham Abdullah was appointed as the Executive Board Member representing the Western Pacific Region. Together,they drove the advocation for equity and access of healthcare service to all,without any discrimination. [61]
Social Recognition and Accolades
On 19 August,he was named as the recipient of the national level Maal Hijrah Figure Award 2020AD/1442AH. [66] Hisham received the Rotary Club's Paul Harris Fellowship,the highest honour given by them to individuals who have contributed to good causes,from the club Kuala Lumpur Chapter on 13 September. [67]
On 17 July,he received the BrandLaureate Award 2020 for Outstanding Brand Leadership along with the 'Certificate of Recognition and Appreciation' for Ministry of Health by the World Brand Foundation. [68] [69] On 18 December,women's magazine Nona honoured him with a special Nona Frontliner Award during the Nona Superwoman Award 2020 presentation. [70] [71] On 20 December,he was presented a special award during the Anugerah MeleTOP Era 2020 (AME 2020) jointly hosted by Astro's both MeleTOP television entertainment programme and ERA radio station. [72] [73]
On 15 December,the Nona magazine presented Hisham again,who had received 2020 Nona Superwoman Award a year earlier,for the main 2021 Nona Superhero Award this time. [74] [75] On 18 December,Hisham awarded 2021 Leadership Award by the Malaysia Public Relations and Communication Association (PRCA) to recognises and honours his dedication in giving interviews to keep the public updated. [76]
In Popular Culture
In October 2020,Noor Hisham appeared as an animated character along with characters from BoBoiBoy franchise in a one-minute public service announcement to remind Malaysians to take steps to prevent COVID-19. [77] [78]
Retirement
On 10 April 2023,it was reported that Hisham would retire from his career after 35 years and being as Director-General of Health for slightly more than a decade on 21 April 2023,as he would reach 60 and the mandatory retirement age for civil servants. [79] Nine-days later on the 19th April 2023,Hisham clocked out for the last time at the Ministry of Health. He said that his post-retirement plan was to take a rest after his long work. [80]
Following retirement from public service,he was appointed as the Chairman of National Heart Institute (Institut Jantung Negara), [8] Chairman of UCSI Healthcare Group [9] and Chancellor of Cyberjaya University. [10]
